Published in Dev Med Child Neurol on August 01, 2008
Current insights in the development of children's motor imagery ability. Front Psychol (2015) 0.77
What should we do to help children with DCD. Dev Med Child Neurol (2008) 0.75
Feasibility of Motor Imagery Training for Children with Developmental Coordination Disorder - A Pilot Study. Front Psychol (2017) 0.75
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol (2013) 5.73
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med (2003) 4.14
The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc (2003) 2.83
Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci U S A (2006) 2.71
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr (2009) 2.54
A genome wide survey of SNP variation reveals the genetic structure of sheep breeds. PLoS One (2009) 2.22
Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (2003) 2.20
Genome sequence of an Australian kangaroo, Macropus eugenii, provides insight into the evolution of mammalian reproduction and development. Genome Biol (2011) 2.18
Determining the extent of cognitive change after coronary surgery: a review of statistical procedures. Ann Thorac Surg (2002) 2.17
Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis (2011) 1.98
An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancer. Eur J Cancer (2012) 1.97
Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol (2006) 1.92
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn (2005) 1.91
Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med (2004) 1.86
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles. PLoS One (2012) 1.77
CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med (2003) 1.76
Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol (2004) 1.59
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology (2006) 1.56
Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. BMC Bioinformatics (2014) 1.53
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. Int J Neuropsychopharmacol (2012) 1.52
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer. Clin Cancer Res (2011) 1.51
Plasma amyloid beta42 and amyloid beta40 levels are associated with early cognitive dysfunction after cardiac surgery. Ann Thorac Surg (2009) 1.50
Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery. Anesthesiology (2015) 1.50
European Academy for Childhood Disability (EACD): recommendations on the definition, diagnosis and intervention of developmental coordination disorder (long version). Dev Med Child Neurol (2012) 1.49
The influence of different error estimates in the detection of postoperative cognitive dysfunction using reliable change indices with correction for practice effects. Arch Clin Neuropsychol (2007) 1.47
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin Cancer Res (2004) 1.44
Genetic variability in complement activation modulates the systemic inflammatory response syndrome in children. Pediatr Crit Care Med (2010) 1.41
White-matter abnormalities in attention deficit hyperactivity disorder: a diffusion tensor imaging study. Hum Brain Mapp (2009) 1.41
Developing the 'youth model' in mental health services. Australas Psychiatry (2008) 1.39
Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev (2006) 1.37
Primary chemotherapy for inoperable ovarian, fallopian tube, or primary peritoneal cancer with or without delayed debulking surgery. Int J Gynecol Cancer (2012) 1.37
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology (2012) 1.31
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain (2013) 1.31
TREM-1 promotes survival during septic shock in mice. Eur J Immunol (2007) 1.27
Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg (2011) 1.27
The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol (2005) 1.26
Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res (2007) 1.26
Natural history of concussion in sport: markers of severity and implications for management. Am J Sports Med (2010) 1.26
Assessing cognitive function in cancer patients. Support Care Cancer (2006) 1.25
Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%. J Sleep Res (2003) 1.22
Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes (2003) 1.19
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. J Clin Exp Neuropsychol (2012) 1.18
A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. J Clin Exp Neuropsychol (2009) 1.17
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging. Neuroimage (2008) 1.15
Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res (2003) 1.15
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Ann Neurol (2013) 1.13
Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry (2007) 1.12
The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis. J Int Neuropsychol Soc (2006) 1.11
The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology (2006) 1.11
Mechanisms for a novel immune evasion strategy in the scabies mite sarcoptes scabiei: a multigene family of inactivated serine proteases. J Invest Dermatol (2003) 1.10
Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biol Psychiatry (2002) 1.10
An examination of the construct validity and factor structure of the Groton Maze Learning Test, a new measure of spatial working memory, learning efficiency, and error monitoring. Arch Clin Neuropsychol (2008) 1.09
Psychological and cognitive assessment of Indigenous Australians. Aust N Z J Psychiatry (2010) 1.07
Spatio-visual memory of children with specific language impairment: evidence for generalized processing problems. Int J Lang Commun Disord (2005) 1.07
Development of a statistical approach to classifying treatment response in individual children with ADHD. Hum Psychopharmacol (2004) 1.06
Behavioral characterization of mild cognitive impairment. J Clin Exp Neuropsychol (2002) 1.06
A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res (2005) 1.06
Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study. Contemp Clin Trials (2006) 1.05
Sequence and organization of the Heliothis virescens ascovirus genome. J Gen Virol (2007) 1.04
Deciphering the genetic basis for polyketide variation among mycobacteria producing mycolactones. BMC Genomics (2008) 1.04
Spectrum of saccade system function in Alzheimer disease. Arch Neurol (2003) 1.03
The prion protein gene: identifying regulatory signals using marsupial sequence. Gene (2005) 1.03
Longer term effect of randomized, controlled group cognitive behavioural therapy for Internet addiction in adolescent students in Shanghai. Aust N Z J Psychiatry (2010) 1.03
International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. BJU Int (2007) 1.02
Highly selective gas sensor arrays based on thermally reduced graphene oxide. Nanoscale (2013) 1.02
Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol. Anesth Analg (2009) 1.02
Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities. Drug Alcohol Rev (2004) 1.01
Strong Souls: development and validation of a culturally appropriate tool for assessment of social and emotional well-being in Indigenous youth. Aust N Z J Psychiatry (2010) 1.01
Episodic memory decline predicts cortical amyloid status in community-dwelling older adults. J Alzheimers Dis (2011) 1.00
Intraindividual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement (2012) 1.00
Diverse sources of C. difficile infection. N Engl J Med (2014) 0.99
Perception of alcohol intoxication shows acute tolerance while executive functions remain impaired. Exp Clin Psychopharmacol (2010) 0.99
Anterior cingulate activation during Stroop task performance: a PET to MRI coregistration study of individual patients with schizophrenia. Am J Psychiatry (2002) 0.98
A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam. Hum Psychopharmacol (2005) 0.98
Rapid decline in episodic memory in healthy older adults with high amyloid-β. J Alzheimers Dis (2013) 0.97
Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010. Alzheimers Dement (2011) 0.97
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. J Alzheimers Dis (2013) 0.96
Antimicrobial strength increases with group size: implications for social evolution. Biol Lett (2010) 0.96
Sero-prevalence of leptospirosis in workers at a New Zealand slaughterhouse. N Z Med J (2009) 0.95
Repeated assessment of cognition in children and the measurement of performance change. Child Neuropsychol (2005) 0.95
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiol Aging (2013) 0.95
Measuring psychosocial risk in families caring for a child with cancer: the Psychosocial Assessment Tool (PAT2.0). Pediatr Blood Cancer (2009) 0.95
Attention, motor control and motor imagery in schizophrenia: implications for the role of the parietal cortex. Schizophr Res (2004) 0.95
Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort. J Am Diet Assoc (2004) 0.95
Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension. Eur Neuropsychopharmacol (2013) 0.95
Structural development of the basal ganglia in attention deficit hyperactivity disorder: a diffusion tensor imaging study. Psychiatry Res (2009) 0.95
Cognitive impairment in Aboriginal people with heavy episodic patterns of alcohol use. Addiction (2007) 0.94
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Arch Clin Neuropsychol (2013) 0.93
The neurobehavioural effects of kava. Aust N Z J Psychiatry (2002) 0.93
Preexisting cognitive impairment and mild cognitive impairment in subjects presenting for total hip joint replacement. Anesthesiology (2011) 0.93
The use of adenosine triphosphate bioluminescence to assess the efficacy of a modified cleaning program implemented within an intensive care setting. Am J Infect Control (2010) 0.93
Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist. Hum Psychopharmacol (2009) 0.92
Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia. PLoS One (2011) 0.92
Aβ amyloid, cognition, and APOE genotype in healthy older adults. Alzheimers Dement (2012) 0.92